Amantadine-based combination therapy of Parkinson’s disease to prevent fluctuation and dyskinesia – experiences from a Parkinson outpatient clinic
BackgroundThe standard therapy of Parkinson’s disease consists in supplementing the depleted dopamine with oral levodopa. The disadvantages of the levodopa monotherapy – comparable to other dopaminergic substances – are the dose-dependent development of dyskinesia in ON-phases, and bradykinesia and...
Gardado en:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-03-01
|
| Series: | Frontiers in Aging Neuroscience |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fnagi.2026.1724003/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|